de Mel, Sanjay
Rashid, Masturah B. M.
Zhang, Xi Yun
Goh, Jasmine
Lee, Chun Tsu
Poon, Li Mei
Chan, Esther H. L.
Liu, Xin
Chng, Wee Joo
Chee, Yen Lin
Lee, Joanne
Yuen, Yi Ching
Lim, Jing Quan
Chia, Burton K. H.
Laurensia, Yurike
Huang, DaChuan http://orcid.org/0000-0002-7518-4081
Pang, Wan Lu
Cheah, Daryl Ming Zhe
Wong, Esther Kam Yin
Ong, Choon Kiat http://orcid.org/0000-0001-6402-4288
Tang, Tiffany
Lim, Soon Thye
Ng, Siok Bian
Tan, Soo Yong
Loi, Hoi-Yin
Tan, Lip Kun
Chow, Edward K.
Jeyasekharan, Anand D. http://orcid.org/0000-0001-9816-6137
Funding for this research was provided by:
National University Cancer Institute, Singapore
MOH | National Medical Research Council
Article History
Received: 5 November 2019
Revised: 5 January 2020
Accepted: 10 January 2020
First Online: 27 January 2020
Conflict of interest
: A.D.J.: honoraria from AstraZeneca, Janssen, and MSD, travel funding from Perkin Elmer, and research funding from Janssen. E.C.; shareholder in KYAN Therapeutics. The other co-authors declare no relevant conflict of interest for this work.